Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis
Main Analysis of Semaglutide OW Comparative Effectiveness with SGLT2is The subset of patients initiating semaglutide OW who did not have baseline or follow-up use of SGLT2i were identified, characterized, and compared with patients initiating SGLT2i after inverse probability of treatment weighting (IPTW), for changes in weight, BMI, HbA1c, composite weight and HbA1c outcomes, all-cause HCRU, and medical costs
For type 2 diabetes, the recommended starting dose of semaglutide is 0.25 mg once weekly
Journal of Clinical Endocrinology & Metabolism, 60(1), 114-119
Retatrutide injection technique The triple agonist retatrutide is also administered subcutaneously